Mostrecent bkllf stock price license#entered into a sponsored research agreement and an exclusive option to license agreement with North Carolina State University to develop a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform.Revive Therapeutics ( RVVTF) +2.1% to $0.49/share. announced it has refiled its interim financial statements for the three and six month period ended September 30, 2020 as they have been restated to reflect certain adjustments resulting from a review by the Company's auditors.Red Light Holland ( TRUFF) N/C $0.22/share.commenced a study to determine the therapeutic values of muscimol for antioxidant and anti-inflammatory purposes.signed a lab services agreement with Optimi Health Corp.(Private) to further the research and development of psilocybin-producing mushrooms.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |